T M Hess|S M Pullen|K A McGee - JoVE Visualize

Showing results (21-30 of 39) with videos related to

Pageof 4

Sort By:

Veterinary Journal (London, England : 1997)|October 1, 2016

Distortion product otoacoustic emissions in geriatric dogsG M Strain, A J Rosado Martinez, K A McGee, et al.

British Journal of Cancer|March 5, 2004

2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPTN A Helsby, D M Ferry, A V Patterson, et al.

Psychology and Aging|May 4, 1999

Trait diagnosticity versus behavioral consistency as determinants of impression change in adulthoodT M Hess, C A Bolstad, S M Woodburn, et al.

Journal of Gerontology|September 1, 1987

Memory for sex-role consistent and inconsistent actions in young and old adultsT M Hess, M O Vandermaas, J Donley, et al.

Minnesota Medicine|April 1, 1990

Treatment of acute herpetic neuralgia. A case report and review of the literatureT M Hess, L J Lutz, L A Nauss, et al.

Environmental and Molecular Mutagenesis|January 1, 1987

Variation in the human lymphocyte sister chromatid exchange frequency as a function of time: results of daily and twice-weekly samplingJ D Tucker, M L Christensen, C L Strout, et al.

Journal of Medicinal Chemistry|June 21, 1996

Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxideH H Lee, W R Wilson, D M Ferry, et al.

Biochemical Pharmacology|September 7, 2000

Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolismB G Siim, K O Hicks, S M Pullen, et al.

Journal of Medicinal Chemistry|April 25, 1997

Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugsB G Siim, G J Atwell, R F Anderson, et al.

Anti-Cancer Drug Design|October 1, 1996

Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductaseG J Atwell, M Boyd, B D Palmer, et al.

Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:

Pageof 4

Veterinary Journal (London, England : 1997)|October 1, 2016

Distortion product otoacoustic emissions in geriatric dogsG M Strain, A J Rosado Martinez, K A McGee, et al.

British Journal of Cancer|March 5, 2004

2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPTN A Helsby, D M Ferry, A V Patterson, et al.

Psychology and Aging|May 4, 1999

Trait diagnosticity versus behavioral consistency as determinants of impression change in adulthoodT M Hess, C A Bolstad, S M Woodburn, et al.

Journal of Gerontology|September 1, 1987

Memory for sex-role consistent and inconsistent actions in young and old adultsT M Hess, M O Vandermaas, J Donley, et al.

Minnesota Medicine|April 1, 1990

Treatment of acute herpetic neuralgia. A case report and review of the literatureT M Hess, L J Lutz, L A Nauss, et al.

Environmental and Molecular Mutagenesis|January 1, 1987

Variation in the human lymphocyte sister chromatid exchange frequency as a function of time: results of daily and twice-weekly samplingJ D Tucker, M L Christensen, C L Strout, et al.

Journal of Medicinal Chemistry|June 21, 1996

Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxideH H Lee, W R Wilson, D M Ferry, et al.

Biochemical Pharmacology|September 7, 2000

Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolismB G Siim, K O Hicks, S M Pullen, et al.

Journal of Medicinal Chemistry|April 25, 1997

Hypoxia-selective antitumor agents. 15. Modification of rate of nitroreduction and extent of lysosomal uptake by polysubstitution of 4-(alkylamino)-5-nitroquinoline bioreductive drugsB G Siim, G J Atwell, R F Anderson, et al.

Anti-Cancer Drug Design|October 1, 1996

Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductaseG J Atwell, M Boyd, B D Palmer, et al.

Pageof 4